An interleukin-2 receptor gamma chain mutation with normal thymus morphology.

N Sharfe, M Shahar, CM Roifman - The Journal of clinical …, 1997 - Am Soc Clin Investig
N Sharfe, M Shahar, CM Roifman
The Journal of clinical investigation, 1997Am Soc Clin Investig
One of the most common human immunodeficiencies is an X-linked condition arising from
mutations of the gamma subunit of the interleukin-2 receptor (IL-2Rgamma). The IL-
2Rgamma protein is one chain of the heterotrimeric (alpha, beta, gamma) IL-2 receptor, but
also participates in the formation of the IL-4, 7, 9, and 15 receptor complexes. The diagnosis
of X-linked SCID is usually relatively simple due to the distinctive immunological
presentation; IL-2Rgamma-deficient patients typically lacking mature T lymphocytes (T-B+) …
One of the most common human immunodeficiencies is an X-linked condition arising from mutations of the gamma subunit of the interleukin-2 receptor (IL-2Rgamma). The IL-2Rgamma protein is one chain of the heterotrimeric (alpha, beta, gamma) IL-2 receptor, but also participates in the formation of the IL-4, 7, 9, and 15 receptor complexes. The diagnosis of X-linked SCID is usually relatively simple due to the distinctive immunological presentation; IL-2Rgamma-deficient patients typically lacking mature T lymphocytes (T-B+). However, it is becoming clear that this merely represents one extreme of a potential range of clinical presentations. We describe here a novel mutation of the human IL-2Rgamma chain (R222C) resulting in an unusual immunological phenotype. Although clinically immunodeficient, this patient has normal numbers of peripheral T and B cells, responds normally to mitogenic stimuli, and unusually, has a normal thymus gland. This IL-2Rgamma mutation is distinctive in that the protein is sufficiently stable to be expressed at the cell surface. While the T cell receptor repertoire appears complete, suggesting normal T cell differentiation occurs, patient T cells demonstrate a reduced ability to bind IL-2 and this appears sufficient to cause a deficiency in their ability to participate in antigenic responses. Early clinical recognition of this phenotype is critical as a delay in diagnosis may result in a fatal infection.
The Journal of Clinical Investigation